X

Health Care

Humana Inc. (HUM) Q2 2022 Earnings Call Transcript

Humana Inc. (NYSE: HUM) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lisa Stoner -- Vice President, Investor Relations Bruce…

Boston Scientific Corp (BSX) Q2 2022 Earnings Call Transcript

Boston Scientific Corp  (NYSE: BSX) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lauren Tengler -- Director of Investor Relations…

MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth

Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues.…

Petmed Express Inc. (PETS) Q1 2023 Earnings Call Transcript

Petmed Express Inc. (NASDAQ: PETS) Q1 2023 earnings call dated Jul. 25, 2022 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer…

TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call Transcript

TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings call dated Jul. 25, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren…

Intuitive Surgical, Inc. (ISRG) Q2 2022 Earnings Call Transcript

Intuitive Surgical, Inc.  (NASDAQ: ISRG) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Brian King -- Treasurer and Head of…

Intuitive Surgical Inc. (ISRG) Earnings: 2Q22 Key Numbers

Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $1.52 billion for the second quarter of 2022, up 4% year-over-year. GAAP…

IQVIA Holdings Inc. (IQV) Q2 2022 Earnings Call Transcript

IQVIA Holdings Inc.  (NYSE: IQV) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor…

Quest Diagnostics Inc. (DGX) Q2 2022 Earnings Call Transcript

Quest Diagnostics Inc.  (NYSE: DGX) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Shawn Bevec -- Vice President of Investor…

Abbott (ABT) Q2 2022 Earnings Call Transcript

Abbott  (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and…

Biogen Inc. (BIIB) Q2 2022 Earnings Call Transcript

Biogen Inc.  (NASDAQ: BIIB) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Michael Hencke -- Head of Investor Relations. Michel…

Anthem, Inc. (ANTM) Q2 2022 Earnings Call Transcript

Anthem, Inc. (NYSE: ANTM) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Stephen Tanal -- Vice President, Investor Relations Gail…

Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript

Johnson & Johnson  (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations…

Novartis AG (NVS) Q2 2022 Earnings Call Transcript

Novartis AG  (NYSE: NVS) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations…

Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers

Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an…

Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results

Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net…

UnitedHealth Group Incorporated (UNH) Q2 2022 Earnings Call Transcript

UnitedHealth Group Incorporated (NYSE: UNH) Q2 2022 earnings call dated Jul. 15, 2022 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk…

Organigram Holdings Inc. (OGI) Q3 2022 Earnings Call Transcript

Organigram Holdings Inc. (NASDAQ: OGI) Q3 2022 earnings call dated Jul. 14, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief…

What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff

Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have…

Despite generic threat, AbbVie (ABBV) remains a good long-term bet

Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from…

Angiodynamics Inc (ANGO) Q4 2022 Earnings Call Transcript

Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer…